Primmune Therapeutics logo

Primmune Therapeutics jobs and careers

San Diego, CA, United States

About Primmune Therapeutics

Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Their goal is to improve the response rate of patients to current and future immunotherapy medicines.

Founded in 2017 by James Appleman and Paulo Rangel.

Founded
2017
Employees
1 to 10
Total funding
$48.3M
Headquarters
San Diego

Leadership

The top of Primmune Therapeutics's org chart, with how many people report into each leader.

CMPhoto of Charles McDermott

Charles McDermott

Chairman, President & CEO

7 reports

JAPhoto of James Appleman

James Appleman

SVP, R&D & CSO Co-Founder, Director

1 report

PRPhoto of Paulo Rangel

Paulo Rangel

Chief Business Officer and Co-founder

1 report

CSPhoto of Curtis Scribner

Curtis Scribner

Chief Medical Officer

MV

Marc Veale

Chief Financial Officer

RDPhoto of Richard Daniels

Richard Daniels

Chief Operating Officer

Board

ANPhoto of Amir Nashat

Amir Nashat

Director

THPhoto of Todd Harris

Todd Harris

Director

EZPhoto of Elina Zuniga

Elina Zuniga

Scientific Advisor

SMPhoto of Sheldon Morris

Sheldon Morris

Clinical Advisor

JMPhoto of Jyoti Mayadev

Jyoti Mayadev

Clinical Advisor

ICPhoto of Isan Chen

Isan Chen

Clinical Advisor